Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

Status unconfirmed

Conditions studied: Smith Magenis Syndrome

In brief

The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes

Key facts

Study ID

NCT02180451

Run by

Vanda Pharmaceuticals

People needed

8

Starts

2014-06-01

Expected to finish

2017-01-01

Last updated by the study team

2016-03-25

Who can join

Age: 6 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A confirmed clinical diagnosis of SMS with a prior positive genetic test result as indicated by a parent/guardian
• Informed consent from the patient or the legal guardian/assent provided by the individual with SMS, when possible
• Male or female between the ages of 6-50 years of age
• History of sleep disturbances
• Willing and able to comply with study requirements and restrictions

You may not qualify if…

• Failure to confirm diagnosis of SMS by molecular cytogenetic methods and/or DNA-based mutation analysis of the RAI1 gene
• Totally blind with no light perception
• Institutionalized or living in an assisted living facility
• Unwilling or unable to follow medication restrictions (medications that affect sleep or melatonin secretion) or unwilling or unable to sufficiently wash-out from use of a restricted medication
• Any medical condition, as determined by the clinical investigator that would make it unsafe for blood draws (e.g., anemia, blood clotting disorders, anxiety, etc.)
• Any other sound medical reason as determined by the clinical investigator

Where it is running

• Study site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.